A team led by Mass General Brigham researchers demonstrated that inebilizumab reduced the risk of symptoms by 87% in patients with the rare affliction known as immunoglobulin G4–related disease (IgG4- ...

Managing diabetes in older adults in India presents unique challenges due to age-related bodily changes and the prevalence of ...

Living with diabetes requires proactive lifestyle management. A balanced diet, regular exercise, and avoiding alcohol and ...

Eight people were killed and 17 others injured after a brutal stabbing attack at the Wuxi Vocational Institute of Arts and ...

Fetch faculty members offer unique insights about behavior associated with diabetes, diabetic ketoacidosis, and new drug ...

Study in Chennai aims to educate persons with diabetes on nutrition for blood sugar control and self-care practices.

Well, Metformin is a drug which is primality used for diabetes; however, people are using it for losing weight too. An expert ...

The international community just marked World Diabetes Day in keeping with the United Nations’ Resolution 61/225. The event ...

Researchers have demonstrated that inebilizumab reduced the risk of symptoms by 87 percent in patients with the rare affliction known as immunoglobulin G4-related disease (IgG4-RD).

For patients with type 2 diabetes mellitus, semaglutide is associated with a reduced risk for a first-time Alzheimer disease (AD) diagnosis compared with other antidiabetic medications.